Top Markets
Coin of the day
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Classificação em ações #6295
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Preço da ação
$115.48
Valor de mercado
$2.12B
Variação (1 dia)
0.72%
Variação (1 ano)
29.38%
País
KR
Negociar Voronoi, Inc. (310210)

Categoria

Histórico de rendimento de dividendos para Voronoi, Inc. (310210)
O rendimento de dividendos (TTM) da Voronoi, Inc. (símbolo da ação: 310210) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Voronoi, Inc. (310210) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH